With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

One of the largest studies ever conducted on the link between the shingles vaccine and brain health offers insight into how the disease increases ...

Alzheimer’s disease impacts tens of millions of families throughout the world, and projections state that more than 100 ...

The shingles vaccine could lower the risk of heart attack and stroke by almost a fifth, according to the first global study of its kind. Researchers reviewed the evidence between the herpes zoster ...

Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash following a series of setbacks for the biotech.

The shingles vaccine is up to 97% effective in preventing the condition caused by the herpes zoster virus, which inflames nerves and causes painful rashes. Now, a new metastudy says it may also be a ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% ​revenue ...

A second dose conferred an additional 67.9% effectiveness against any herpes zoster outcome. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including ...

Participants were Medicare beneficiaries aged 65 years or older with continuous Part D coverage, with no prior RZV vaccination. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are ...